naltrexone
Showing 1 - 25 of 144
Advanced Melanoma Trial in New Brunswick (Propranolol, Naltrexone)
Not yet recruiting
- Advanced Melanoma
- Propranolol
- Naltrexone
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jul 18, 2023
Covid19, Long COVID-19, Post-COVID-19 Syndrome Trial in Ann Arbor (Naltrexone, NAD+)
Completed
- Covid19
- +2 more
- Naltrexone
- NAD+
-
Ann Arbor, MichiganAgelessRx
Jan 23, 2023
Covid19 Trial in Saint Louis Park, Saint Paul (Colchicine 0.6 mg, Naltrexone)
Completed
- Covid19
- Colchicine 0.6 mg
- Naltrexone
-
Saint Louis Park, Minnesota
- +1 more
Jan 10, 2023
Cutaneous Nerves CNS Itch Trial in Minneapolis (Clonidine, Naltrexone)
Completed
- Cutaneous Nerves CNS Itch
- Clonidine
- Naltrexone
-
Minneapolis, MinnesotaUniversity of Minnesota Department of Dermatology
Jan 23, 2023
Dry Eye Disease Trial in Memphis (Naltrexone, Placebos)
Completed
- Dry Eye Disease
- Naltrexone
- Placebos
-
Memphis, TennesseeTotal Eye Care
Nov 16, 2022
Eating Disorders, Binge Eating, Purging (Eating Disorders) Trial in Kansas City (Naltrexone)
Completed
- Eating Disorders
- +2 more
- Naltrexone
-
Kansas City, MissouriChildren's Mercy Research Institute
Aug 17, 2022
Alcohol Use Disorder Trial in Houston (Lemborexant 10 mg, Naltrexone)
Not yet recruiting
- Alcohol Use Disorder
- Lemborexant 10 mg
- Naltrexone
-
Houston, TexasThe Menninger Clinic
Aug 11, 2022
Bladder Pain Syndrome, Interstitial Cystitis Trial in Stanford (Naltrexone, Placebo)
Recruiting
- Bladder Pain Syndrome
- Interstitial Cystitis
- Naltrexone
- Placebo
-
Stanford, CaliforniaStanford Health Care
Jul 7, 2022
Painful Diabetic Neuropathy Trial in Lebanon (Naltrexone, Placebo)
Recruiting
- Painful Diabetic Neuropathy
- Naltrexone
- Placebo
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Aug 9, 2022
Eating Disorders, Binge Eating, Purging (Eating Disorders) Trial in Kansas City (Naltrexone, Placebo)
Not yet recruiting
- Eating Disorders
- +4 more
- Naltrexone
- Placebo
-
Kansas City, MissouriChildren's Mercy Research Institute
Aug 18, 2022
Endometriosis Trial in Hershey (Naltrexone, Norethindrone Acetate, Placebo)
Recruiting
- Endometriosis
- Naltrexone
- +2 more
-
Hershey, PennsylvaniaPenn State Hershey Medical Center
Apr 22, 2022
Melanoma, Prostate Cancer, Renal Cancer Trial in Providence (Naltrexone)
Terminated
- Melanoma
- +2 more
- Naltrexone
-
Providence, Rhode IslandMiriam Hospital
Feb 23, 2022
Atopic Dermatitis, Pruritus, Pruritus Chronic Trial in Minneapolis (Naltrexone, Placebo)
Not yet recruiting
- Atopic Dermatitis
- +3 more
- Naltrexone
- Placebo
-
Minneapolis, MinnesotaUniversity of Minnesota
Feb 25, 2022
Heroin Dependence, Opioid Dependence Trial in Philadelphia (Naltrexone)
Completed
- Heroin Dependence
- Opioid Dependence
- Naltrexone
-
Philadelphia, PennsylvaniaCenter for the Studies of Addiction
Feb 11, 2022
Alcohol Use Disorder Trial in Los Angeles (Placebo, Naltrexone, Varenicline)
Completed
- Alcohol Use Disorder
- Placebo
- +2 more
-
Los Angeles, CaliforniaUCLA Addictions Lab
Oct 10, 2022
COVID-19, Acute Respiratory Distress Syndrome, Severe Acute Respiratory Syndrome (SARS) Trial in Royal Oak (Naltrexone,
Terminated
- COVID-19
- +3 more
- Naltrexone
- +2 more
-
Royal Oak, MichiganWilliam Beaumont Hospital
Jan 12, 2022
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in New Haven (Naltrexone, Placebo)
Completed
- Schizophrenia
- +4 more
- Naltrexone
- Placebo
-
New Haven, ConnecticutConnecticut Mental Health Center
Sep 3, 2021
Alcohol Drinking, Opioid Use, Unspecified Trial in Aurora (Naltrexone, Placebo)
Completed
- Alcohol Drinking
- Opioid Use, Unspecified
- Naltrexone
- Placebo
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Aug 10, 2022
Invasive Breast Cancer (Stage I-III), Ductal Carcinoma in Situ, Lobular Carcinoma in Situ Trial in Boston (Naltrexone, Sugar
Terminated
- Invasive Breast Cancer (Stage I-III)
- +4 more
- Naltrexone
- Sugar Pill
-
Boston, Massachusetts
- +1 more
Nov 12, 2021
Opioid-use Disorder Trial in New York (Buprenorphine, Naltrexone, Vivitrol)
Terminated
- Opioid-use Disorder
- Buprenorphine
- +2 more
-
New York, New YorkNew York State Psychiatric Institute
Feb 4, 2022
Atopic Dermatitis, Pruritus, Dermatitis Trial in Minneapolis (Naltrexone, Placebo Cream)
Withdrawn
- Atopic Dermatitis
- +2 more
- Naltrexone
- Placebo Cream
-
Minneapolis, MinnesotaUniversity of Minnesota
Apr 15, 2021